Akero Therapeutics Inc. (AKRO)
43.58
0.29 (0.67%)
At close: Mar 27, 2025, 3:59 PM
46.51
6.72%
After-hours: Mar 27, 2025, 07:59 PM EDT
Akero Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
75
Upside
72.10
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Ed Arce (0.01)
| HC Wainwright & Co. | Strong Buy | Maintains | 72 75 | Mar 3, 2025 |
Eliana Merle (0)
| UBS | Strong Buy | Maintains | 42 109 | Jan 31, 2025 |
| B of A Securities | Strong Buy | Upgrades | 35 63 | Jan 30, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.